Doxycycline (Unidox Solutab®) and/or josamycin (Wilprafen®) in treatment of patients with prostatitis in real clinical practice. Results of the TAURUS observational program


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Treatment of chronic prostatitis is a vital and complicated problem, in which a large number of stamps and «stereotyped» approaches often result in uncured patients. The increasing use of intracellular microorganisms in prostatitis etiology requires a modification in the standard approaches. TAU RU S study shows high efficacy of doxycycline (Unidox Solutab ®) and /or josamycin (Wilprafen®) in chronic prostatitis. Therapy, studied in this program, according to physicians, was effective in 93.2% of patients. Treatment failure was observed in 1.3% of all patients, another 5.5% of patients had insufficient data for assessment. Low incidence of adverse reactions was observed. In the study population, adverse reactions occurred in 2.6% of patients, of them serious adverse events were registered in 0.7% of patients. The most common adverse event in all treatment groups was diarrhea.

Full Text

Restricted Access

About the authors

A. Z Vinarov

First MSMU n.a. I.M. Sechenov

Urology Department

S. V Stojlov

State Clinic №180 of the Department of Health of Moscow

Email: s.stoylov@rambler.ru
Urology Department

S. V Kozyrev

Scientific Research Institute of Urology of the Ministry of health of Russia

V. N Surikov

3rd Clinic of the Administrative Department of the President of Russian Federation

Urology Department

A. V Chaban

State Clinic №27 of the Department of Health of Moscow

Urology Department

D. G Kurbatov

Andrology and Urology Department of the Endocrinological Scientific Center

E. S Shpilenja

North-Western State Medical University n.a. I.I. Mechnikov

Department of Urology

A. I Nejmark

Altai State Medical University

Urology and Nephrology Department

References

  1. Nickel J.C., Downey J., Hunter D., Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001; 165:842-845.
  2. Choi Y.S., Kim K.S., Choi S.W., Kim S., Bae W.J., Cho H.J., Hong S.H., Kim S.W., Hwang T.K., Lee J.Y. Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea. Prostate Int. 2013;1(3):133-138.
  3. Nassar F.A., Abu-Elamreen F.H., Shubair M.E., Sharif F.A. Detection of Chlamydia trachomatis and Mycoplasma hominis, genitalium and Ureaplasmaurealyticum by polymerase chain reaction in patients with sterile pyuria. Adv. Med. Sci. 2008;53(1):80-86.
  4. Винаров А.З., Аляев Ю.Г., Фиев Д.Н., Барыкова Ю.А., Винарова Н.А., Логунов Д.Ю., Шмаров М.М., Народицкий Б.С., Гудков А.В., Гинцбург А.Л. Микоплазменная инфекция предстательной железы и ее возможная роль в патогенезе рака простаты. Андрология и генитальная хирургия. 2009;4:18-22.
  5. Grabe M., Bjerklund-Johansen T.E., Botto H., Çek M., Naber K.G., Pickard R.S., Tenke P., Wagenlehner F., Wullt B. 2013 EAU Guidelines on Urological Infections.
  6. Wagenlehner F., Roscher K., Naber K.G. Practice management of chronic bacterial prostatitis with levofloxacin. Aktuelle Urol. 2011;42(3):184-89.
  7. Cai T., Mazzoli S., Meacci F., Boddi V., Mondaini N., Malossini G., Bartoletti R. Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis. J Microbiol. 2011;49(3):448-454
  8. Vicari E. Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection. Hum Reprod. 2000;15(12):2536-2544.
  9. Yan Z.H., Zhou M., Zhang W., Zhang D.L. Prevalence and drug tolerance of mycoplasma in patients with urogenital inflammation Zhonghua Nan KeXue. 2003;9(8):599-600, 603.
  10. Восканян Г.А., Винаров А.З. Антибактериальная терапия больных хроническим простатитом: поиск выхода из терапевтического «тупика». Урология. 2014;3:89-94.
  11. Рязанцев Е.В., Голоднова Т.Б., Рязанцева И.Е., Плигузов С.А. Психосоматические заболевания при хроническом простатите, осложненном эректильной дисфункцией. Материалы IX Конгресса «Мужское здоровье». СПб., 1-3 июля 2013. C. 27-29.
  12. Стандарт медицинской помощи больным простатитом. Сборник стандартов оказания амбулаторно-поликлинической медицинской помощи. Приложение к приказу Министерства здравоохранения и социального развития РФ от 22.11.2004.
  13. Положения Национального стандарта Российской Федерации «Надлежащая клиническая практика» (ГОСТ Р52379-2005) от 25.09.2005.
  14. Скрипкин Ю.К., Кубанова А.А., Шарапова Г.Я., Селицкий Г.Д. Инфекции, передаваемые половым путем. М., МЕДпресс. 1999. 189 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies